Compelling results set new clinical standard in generalized myasthenia gravis (gMG), increasing confidence in the Company's registrational KYSA-6 Phase 3 MG trial 100% of patients achieved clinically ...

As Trump pushes to cap international students, Harvard welcomes its most global class ever — 15% from abroad, 92 countries, ...

The new biotech Elevara plans to initiate Phase II testing of its lead candidate ELV001 as an add-on treatment for rheumatoid ...

BMY's growth-driving portfolio increased 17% year-over-year, prompting an upward revision in 2025 revenue guidance and ...

Transcatheter arterialization of the deep veins for chronic limb-threatening ischemia in no-option patients kept most ...

More than one‐third of the world's population uses a writing system that includes both uppercase and lowercase letter forms.

Cash and investments are sufficient to fund current operations through Q2 2027, not including VenoValve commercialization and ...

Zocilurtatug pelitecan shows promising results as a DLL3-targeted therapy for small cell lung cancer, with high response rates and ongoing trials.

Two Presentations at ASH 2025 to highlight preclinical data and clinical development plans for GB3226, a novel dual ENL-YEATS and FLT3 inhibitor ...

Students preparing for their CBSE Class 10 English Board Exam 2026 need a structured approach to cover grammar, writing, literature, and reading effectively. This 4 month study plan will help them ...

The National Council of Educational Research and Training (NCERT) has included Ayurveda in the science curriculum following ...

CHICAGO -- Hitting rheumatoid arthritis (RA) early and hard, with targeted therapies as first-line treatment, appears to ...